Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin.

Region Region EU (European Union)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 European Commission (EC)
  Group EU (govt)
Products Product Xarelto®
  Product 2 acetyl salicylic acid (INN s)
Person Person Möller, Jörg (Bayer 201403 Bayer HealthCare Head of Global Development)
     


   
Record changed: 2018-08-28

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px




» top